Skip to content

Clinical trials

Phase 3 Epilepsy trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 3 Country / region: Brazil Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20043
20051
20063
20071
20081
20101
20111
20141
20153
20191
20202
20231
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting3
Recruiting2
Enrolling by invitation2
Suspended1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB BIOSCIENCES, Inc.5
GlaxoSmithKline4
UCB Pharma4
Longboard Pharmaceuticals3
Praxis Precision Medicines3
Ache Laboratorios Farmaceuticos S.A.2
Novartis Pharmaceuticals2
Antonio Waldo Zuardi1
Bial - Portela C S.A.1
Hospital Sirio-Libanes1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy27
Seizures11
Epilepsies, Partial5
Neurodevelopmental Disorders3
Epilepsies, Myoclonic2
Epilepsy, Tonic-Clonic2
Headache2
Lennox Gastaut Syndrome2
Migraine Disorders2
Brain Injuries1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.